Dr. Jeanyoung Kim, MD

Dr. Kim practices at Columbia University Irving Medical Center in New York, New York.

Dr. Kim's NPI, 1811215270, was assigned on May 10, 2010. Dr. Kim's New York license number on file is 285223.

Dr. Kim's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 305-4920.

Dr. Kim's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Kim is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Weill Cornell Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices. Vendor and product names are available with a free account.

Dermatology is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kim is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Kim's licenses on file in 4 states: New York, California, New Jersey and Pennsylvania.

Dmand AI lists acne, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes, psoriasis and rash among the conditions Dr. Kim treats.

CMS data shows 921 Medicare services from Dr. Kim across 12 procedure codes in 2024, for 367 Medicare patients. Medicare paid $67,701 for them. Every service was in an office.

CMS counts 367 Medicare patients who saw Dr. Kim in 2024. The largest group is 65 to 74, with 182 patients. 73% of them have high cholesterol, and 57% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 49, with 65% women.

In 2024, Dr. Kim wrote 1,171 Medicare Part D claims for 290 patients. 85% of them were for generic drugs. CMS names the drug for 971 of them, across 28 drugs with 11 or more claims each, at $359,593 in total drug cost. In 2023, CMS named 760 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kim for performance year 2024, reported through an alternative payment model (APM). Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kim as offering telehealth. CMS counts 272 procedures of removal of skin lesions by Dr. Kim, more than 81% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Kim, published from 2023 to 2024. Dr. Kim's most frequent co-author is Jia Ruan, MD, PhD.

CMS Open Payments shows 77 general payments to Dr. Kim from 21 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 98% of the total. Mayne Pharma Inc. paid the most, $231.

Dr. Kim is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.